The latest in funding & deals: 5 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: UK startup snares $20m to recreate gigs with ‘hyper-realistic’ digital avatars.
Electra’s Upsized IPO Lands $350M for New Class of Precision Immunology Drugs
Electra Therapeutics’ IPO cash will support a potential first-in-class drug whose lead indication is a rare hyperinflammatory disorder with no FDA-approved treatments. Meanwhile, clinical-stage biotechs Marea Therapeutics and Sensorion revealed their respective plans to enter the U.S. public markets. The post Electra’s Upsized IPO Lands $350M for New Class of Precision Immunology Drugs appe…
Angle Health Raises $600M to Grow Employer Health Benefits Platform
Angle Health’s funding round was led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator. The post Angle Health Raises $600M to Grow Employer Health Benefits Platform appeared first on MedCity News.
Follow the full firehose on the HTC Wire, refreshed automatically every day.